Adherence and factors associated with influenza vaccination among subjects with asthma in Spain
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Influenza has a high morbidity and mortality rate and an increased risk of complications in vulnerable individuals. Children and adults with asthma have a high risk of complications, hospitalisation and even death. The objectives of this study were as follows: to compare influenza vaccination coverage in Spain in a population of asthmatics aged ≥16 years with an equivalent population of non-asthmatics; to identify the factors that influence vaccination coverage among patients with asthma; and to compare coverage during the period 2006/2007 with that of 2009/2010.
We used data from the 2009 European Health Survey (EHS), which included a population of 22,188 individuals (≥16 years of age), of whom 1,669 [7.5 %; 95 % confidence interval (CI), 7.13–7.98] had asthma. The dependent variable was the answer (yes/no) to a question asking whether or not the interviewed person had been vaccinated against seasonal (not pandemic) influenza in the previous season. As independent variables, we analysed socio-demographic characteristics, health-related variables and the use of health care services.
Vaccination coverage was 35.2 % (95 % CI, 32.5–37.9) among asthmatics and 22.1 % (95 % CI, 21.4–22.7) among non-asthmatics (p < 0.001). The probability of being vaccinated is almost twice as high for asthmatics as it is for non-asthmatics [odds ratio (OR), 1.92; 95 % CI, 1.69–2.17]. Among asthmatics, vaccination coverage increased with age, worse self-rated health status and not smoking. No significant change in coverage was observed between the study periods.
Seasonal influenza vaccination coverage among Spanish asthmatics is lower than desired and has not improved in recent years. Urgent strategies are necessary in order to increase vaccination coverage among asthmatics.
- Dao CN, Kamimoto L, Nowell M, et al. Adult hospitalizations for laboratory-positive influenza during the 2005–2006 through 2007–2008 seasons in the United States. J Infect Dis. 2010;202:881–8. CrossRef
- Cohen L, Castro M. The role of viral respiratory infections in the pathogenesis and exacerbation of asthma. Semin Respir Infect. 2003;18:3–8. CrossRef
- Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59:1–62.
- Williams SG, Schmidt DK, Redd SC, et al. Key clinical activities for quality asthma care. Recommendations of the National Asthma Education and Prevention Program. MMWR Recomm Rep. 2003;52:1–8.
- Castro M, Dozor A, Fish J, et al. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med. 2001;345:1529–36. CrossRef
- Cates CJ, Jefferson TO, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev. 2008;2:CD000364.
- Tata LJ, West J, Harrison T, et al. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax. 2003;58:835–9. CrossRef
- Hak E, Hoes AW, Grobbee DE, et al. Conventional influenza vaccination is not associated with complications in working-age patients with asthma or chronic obstructive pulmonary disease. Am J Epidemiol. 2003;157:692–700. CrossRef
- Hak E, Buskens E, van Essen GA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med. 2005;165:274–80. CrossRef
- Mereckiene J, Cotter S, Nicoll A, et al.; VENICE Project Gatekeepers Group. National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill. 2008;13.pii:19017. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19017.
- Ministerio de Sanidad (Ministry for Health). Vacunaciones en adultos. 2009. http://www.msc.es/ciudadanos/proteccionSalud/vacunaciones/docs/recoVacunasAdultos.pdf. Accessed 9 Jan 2009.
- Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among persons with asthma—United States, 2005–06 influenza season. MMWR Morb Mortal Wkly Rep. 2008;57:653–7.
- Ford ES, Williams SG, Mannino DM, et al. Influenza vaccination coverage among adults with asthma: findings from the 2000 Behavioral Risk Factor Surveillance System. Am J Med. 2004;116:555–8. CrossRef
- López-de-Andrés A, Carrasco-Garrido P, Hernández-Barrera V, et al. Coverages and factors associated with influenza vaccination among subjects with chronic respiratory diseases in Spain. Eur J Public Health. 2008;18:173–7. CrossRef
- Sánchez Callejas A, Campins Martí M, Martínez Gómez X, et al. Influenza vaccination in patients admitted to a tertiary hospital. Factors associated with coverage. An Pediatr (Barc). 2006;65:331–6. CrossRef
- Vozoris NT, Lougheed MD. Influenza vaccination among Canadians with chronic respiratory disease. Respir Med. 2009;103:50–8. CrossRef
- Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, et al. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet. 1998;351:326–31. CrossRef
- Instituto Nacional de Estadística (National Statistics Institute). Encuesta Europea de Salud en España. European Health Survey Project 2009 (EES09). http://www.ine.es/.
- Lu PJ, Euler GL, Callahan DB. Influenza vaccination among adults with asthma findings from the 2007 BRFSS survey. Am J Prev Med. 2009;37:109–15. CrossRef
- Keenan H, Campbell J, Evans PH. Influenza vaccination in patients with asthma: why is the uptake so low? Br J Gen Pract. 2007;57:359–63.
- Marquet RL, Bartelds AI, van Noort SP, et al. Internet-based monitoring of influenza-like illness (ILI) in the general population of the Netherlands during the 2003–2004 influenza season. BMC Public Health. 2006;6:242. CrossRef
- Nunes B, Contreiras T, Falcão JM. Influenza vaccination: coverage of Portuguese population from 1998/1999 a 2002/2003. Rev Port Pneumol. 2004;10:115–23.
- Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, et al. Coverage and predictors of adherence to influenza vaccination among Spanish children and adults with asthma. Infection. 2010;38:52–7. CrossRef
- McCoy K, Shade DM, Irvin CG, et al. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol. 2006;118:1226–33. CrossRef
- Bedford D, Howell F, Corcoran R. The provision of influenza vaccine to patients over 65 years by general practitioners. Ir Med J. 1997;90:231–2.
- Briss PA, Rodewald LE, Hinman AR, et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med. 2000;18:97–140. CrossRef
- Llupià A, García-Basteiro AL, Mena G, et al. Vaccination behaviour influences self-report of influenza vaccination status: a cross-sectional study among health care workers. PLoS One. 2012;7:e39496. CrossRef
- Skull SA, Andrews RM, Byrnes GB, et al. Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients. Vaccine. 2007;25:4775–83. CrossRef
- Hutchison BG. Measurement of influenza vaccination status of the elderly by mailed questionnaire: response rate, validity and cost. Can J Public Health. 1989;80:271–5.
- Nichol KL, Korn JE, Baum P. Estimation of outpatient risk characteristics and influenza vaccination status: validation of a self-administered questionnaire. Am J Prev Med. 1991;7:199–203.
- Mac Donald R, Baken L, Nelson A, et al. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med. 1999;16:173–7. CrossRef
- Zimmerman RK, Raymund M, Janosky JE, et al. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine. 2003;21:1486–91. CrossRef
- Andrews RM. Assessment of vaccine coverage following the introduction of a publicly funded pneumococcal vaccine program for the elderly in Victoria, Australia. Vaccine. 2005;23:2756–61. CrossRef
- Mangtani P, Shah A, Roberts JA. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect. 2007;135:139–43. CrossRef
- Irving SA, Donahue JG, Shay DK, et al. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine. 2009;27:6546–9. CrossRef
- Williams WW, Lu PJ, Lindley MC, et al. Influenza vaccination coverage among adults—National Health Interview Survey, United States, 2008–09 influenza season. MMWR Morb Mortal Wkly Rep. 2012;61:65–72.
- Loerbroks A, Stock C, Bosch JA, et al. Influenza vaccination coverage among high-risk groups in 11 European countries. Eur J Public Health. 2012;22:562–8. CrossRef
- Guthmann JP, Fonteneau L, Bonmarin I, et al. Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010–2011. Vaccine. 2012;30:995–7. CrossRef
- Caban-Martinez AJ, Lee DJ, Davila EP, et al. Sustained low influenza vaccination rates in US healthcare workers. Prev Med. 2010;50:210–2. CrossRef
- Adherence and factors associated with influenza vaccination among subjects with asthma in Spain
Volume 41, Issue 2 , pp 465-471
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Preventive Medicine and Public Health Department, Faculty of Medicine, Complutense University, Madrid, Spain
- 2. Preventive Medicine Unit, Rey Juan Carlos University, Avda. de Atenas s/n, Alcorcón, Madrid, Spain
- 3. Unidad de Docencia e Investigación en Medicina Preventiva y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avda. de Atenas s/n, 28922, Alcorcón, Madrid, Spain